Evidence map›Paper›PMID 21350178›Full record

ArticleScience (New York, N.Y.)2011

Development of transgenic fungi that kill human malaria parasites in mosquitoes.

Weiguo Fang, Joel Vega-Rodríguez, Anil K Ghosh, Marcelo Jacobs-Lorena, Angray Kang, Raymond J St Leger

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed, 1 pooled it
36.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 1 synthesis or guideline pooled it, 281 citations in OpenAlex.

  1. Fungal microbiota diversity inWellcome open research · 2026
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Isolation of a NovelJournal of fungi (Basel, Switzerland) · 2024
    Article
  12. Article
  13. Dual suppression ofFrontiers in microbiology · 2024
    Article
  14. Article
  15. AVirulence · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Weiguo FangDepartment of Entomology, University of Maryland, 4112 Plant Sciences Building, College Park, MD 20742, USA.
Joel Vega-Rodríguez
Anil K Ghosh
Marcelo Jacobs-Lorena
Angray Kang
Raymond J St Leger
University of Maryland, College Park · US

Funding

Targeting mosquito organs with phage display librariesR01AI031478 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO · 1991 to 2018
$6.0M
Reducing malaria transmission with engineered bacteriaR21AI088033 · NIAID · JOHNS HOPKINS UNIVERSITY · PI JACOBS-LORENA, MARCELO, LAMPE, DAVID J · 2010 to 2011
$453k
Vector biology-Using a mosquito pathogen as a delivery system for anti-malarial aR21AI079429 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI JACOBS-LORENA, MARCELO, ST LEGER, RAYMOND J · 2009 to 2010
$397k
NIAID NIH HHS R01 AI031478NIAID NIH HHS R21 AI079429NIAID NIH HHS R21 AI088033PHS HHS 5R21A1079429-02
6 · The paper itself

Abstract

Metarhizium anisopliae infects mosquitoes through the cuticle and proliferates in the hemolymph. To allow M. anisopliae to combat malaria in mosquitoes with advanced malaria infections, we produced recombinant strains expressing molecules that target sporozoites as they travel through the hemolymph to the salivary glands. Eleven days after a Plasmodium-infected blood meal, mosquitoes were treated with M. anisopliae expressing salivary gland and midgut peptide 1 (SM1), which blocks attachment of sporozoites to salivary glands; a single-chain antibody that agglutinates sporozoites; or scorpine, which is an antimicrobial toxin. These reduced sporozoite counts by 71%, 85%, and 90%, respectively. M. anisopliae expressing scorpine and an [SM1](8):scorpine fusion protein reduced sporozoite counts by 98%, suggesting that Metarhizium-mediated inhibition of Plasmodium development could be a powerful weapon for combating malaria.

Indexed as

AnimalsAnophelesAntibodies, ProtozoanBase SequenceCloning, MolecularDefensinsFeeding BehaviorFemaleHemolymphHumansInsect VectorsMalaria, FalciparumMetarhiziumMolecular Sequence DataOligopeptidesOrganisms, Genetically ModifiedAntibodies, Protozoancircumsporozoite protein, ProtozoanDefensinsOligopeptidesProtozoan ProteinsscorpineSM1 peptide

Identifiers

PMID21350178
PMCPMC4153607
OpenAlexW2130379255

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.